These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1583411)

  • 21. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum interleukin-6 concentrations in patients with alcoholic liver disease].
    Swiatkowska-Stodulska R; Bakowska A
    Pol Merkur Lekarski; 2004 Sep; 17(99):255-9. PubMed ID: 15628053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis.
    Maltby J; Wright S; Bird G; Sheron N
    Hepatology; 1996 Nov; 24(5):1156-60. PubMed ID: 8903391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic 60-kD heat-shock protein responses in alcoholic hepatitis.
    Koskinas J; Winrow VR; Bird GL; Lau JY; Portmann BC; Blake DR; Alexander GJ; Williams R
    Hepatology; 1993 Jun; 17(6):1047-51. PubMed ID: 8514253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.
    Schäfer C; Schips I; Landig J; Bode JC; Bode C
    Z Gastroenterol; 1995 Sep; 33(9):503-8. PubMed ID: 8525652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin 6 in the prognosis of acute biliary pancreatitis.
    Pezzilli R; Miniero R; Cappelletti O; Barakat B
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):291-4. PubMed ID: 9759598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.
    Palombo JD; Burke PA; Moldawer LL; Forse RA; Lewis WD; Jenkins RL
    J Am Coll Surg; 1994 Aug; 179(2):209-19. PubMed ID: 7519108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines and acute-phase response markers derangements in patients with obstructive jaundice.
    Padillo FJ; Andicoberry B; Muntane J; Lozano JM; Miño G; Sitges-Serra A; Solorzano G; Pera-Madrazo C
    Hepatogastroenterology; 2001; 48(38):378-81. PubMed ID: 11379313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome].
    Duan ZP; Chen Y; Zhang J; Zhao J; Lang ZW; Meng FK; Bao XL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):493-6. PubMed ID: 12939186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-8 in alcoholic liver disease.
    Bird G
    Acta Gastroenterol Belg; 1994; 57(3-4):255-9. PubMed ID: 7810274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma tumor necrosis factor in severe alcoholic hepatitis.
    Bird GL; Sheron N; Goka AK; Alexander GJ; Williams RS
    Ann Intern Med; 1990 Jun; 112(12):917-20. PubMed ID: 2339855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis.
    Glavind E; Aagaard NK; Grønbæk H; Møller HJ; Orntoft NW; Vilstrup H; Thomsen KL
    PLoS One; 2016; 11(7):e0158388. PubMed ID: 27379798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
    Tilg H; Jalan R; Kaser A; Davies NA; Offner FA; Hodges SJ; Ludwiczek O; Shawcross D; Zoller H; Alisa A; Mookerjee RP; Graziadei I; Datz C; Trauner M; Schuppan D; Obrist P; Vogel W; Williams R
    J Hepatol; 2003 Apr; 38(4):419-25. PubMed ID: 12663232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malondialdehyde as a Prognostic Factor in Alcoholic Hepatitis.
    Pérez-Hernández O; González-Reimers E; Quintero-Platt G; Abreu-González P; Vega-Prieto MJ; Sánchez-Pérez MJ; Martín-González C; Martínez-Riera A; Santolaria-Fernández F
    Alcohol Alcohol; 2017 May; 52(3):305-310. PubMed ID: 28007738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis.
    McClain CJ; Cohen DA; Dinarello CA; Cannon JG; Shedlofsky SI; Kaplan AM
    Life Sci; 1986 Oct; 39(16):1479-85. PubMed ID: 3490610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis.
    Felver ME; Mezey E; McGuire M; Mitchell MC; Herlong HF; Veech GA; Veech RL
    Alcohol Clin Exp Res; 1990 Apr; 14(2):255-9. PubMed ID: 2190492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay of serum interleukin 8 levels in patients with alcoholic hepatitis.
    Masumoto T; Onji M; Horiike N; Ohta Y
    Alcohol Alcohol Suppl; 1993; 1A():99-102. PubMed ID: 7908198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis.
    Hillan KJ; Logan MC; Ferrier RK; Bird GL; Bennett GL; McKay IC; MacSween RN
    J Hepatol; 1996 Apr; 24(4):385-90. PubMed ID: 8738723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.